Polymyositis: Difference between revisions

No edit summary
 
(20 intermediate revisions by 8 users not shown)
Line 1: Line 1:
==Background==
==Background==
Idiopathic inflammatory myopathy causing symmetric proximal muscle weakness, elevated CK,and characteristic EMG findings
*Idiopathic inflammatory myopathy causing symmetric proximal muscle weakness, elevated CK, and characteristic EMG findings


==Clinical Features==
==Clinical Features==
* Symmetrical proximal muscle weakness with insidious onset
*Symmetrical proximal muscle [[weakness]] with insidious onset
* Generally painless (though 30% have myalgia)  
*Generally painless (though 30% have [[myalgia]])  
* Difficulty with kneeling, climbing stairs, combing hair, or rising from a seated position
*Difficulty with kneeling, climbing stairs, combing hair, or rising from a seated position
* Weak neck extensors causing difficulty of holding head up
*Weak neck extensors causing difficulty of holding head up
* Associated arthralgias
*Associated arthralgias


==Differential Diagnosis==
==Differential Diagnosis==
* Hypokalemia
{{Myalgia DDX}}
* Hypophosphatemia
* Thyroid disorder (hypothyroidism or hyperthyroidism)
* Myopathies
* Inclusion body myositis
* Drug Induced myopathies (EtOH, antimalarials, colchicine, antifungals)


{{Weakness DDX}}
{{Weakness DDX}}


==Diagnosis==
==Evaluation==
* CBC, ESR, CRP, CK, UA, RF, ANA, Anti-Jo-1
 
===Workup===
*CBC
*ESR
*CRP
*CK: Most sensitive muscle enzyme
*[[Urinalysis]]
*Consider:
**LDH
**AST/ALT
**Aldolase
**RF
**ANA
**Anti-Jo-1
**Myositis antibody panel
 
===Diagnosis===
*Typically requires muscle biopsy


==Management==
==Management==
* Prednisone 1mg/kg/day for 4-8 weeks until CK returns to reference range
*[[Prednisone]] 1mg/kg/day for 4-8 weeks until CK returns to reference range
* Followed by prednisone taper
**Followed by [[prednisone]] taper
* Methotrexate as second line for poor response to corticosteroids
*Other treatments that rheum may prescribe:
* Other agents with less evidence: IVIG, TNF Inhibitors
**[[Methotrexate]] as second line for poor response to corticosteroids
 
**Other agents with less evidence: IVIG, TNF Inhibitors
==Disposition==
*Assess for [[interstitial lung disease]]
*Rheumatology or neurology consultation either in ED or as outpatient depending on severity of symptoms
**[[CXR]], consider CT chest
*Very strongly associated with malignancy (~30%), especially:<ref>Hill CL et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001 Jan 13;357(9250):96-100.</ref>
**Pulmonary function tests (PFTs)
*Screen for associated malignancy, especially:<ref>Hill CL et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001 Jan 13;357(9250):96-100.</ref>
**Ovarian
**Ovarian
**Lung
**Lung
Line 38: Line 51:
**Lymphoma
**Lymphoma
**Bladder
**Bladder
==Disposition==
*Rheumatology or neurology consultation either in ED or as outpatient depending on severity of symptoms
==See Also==
*[[Weakness]]


==References==
==References==
Tintinalli
<references/>


[[Category:Rheum]]
[[Category:Rheumatology]]
[[Category:Neuro]]
[[Category:Neurology]]

Latest revision as of 08:35, 15 December 2022

Background

  • Idiopathic inflammatory myopathy causing symmetric proximal muscle weakness, elevated CK, and characteristic EMG findings

Clinical Features

  • Symmetrical proximal muscle weakness with insidious onset
  • Generally painless (though 30% have myalgia)
  • Difficulty with kneeling, climbing stairs, combing hair, or rising from a seated position
  • Weak neck extensors causing difficulty of holding head up
  • Associated arthralgias

Differential Diagnosis

Myalgia

Weakness

Evaluation

Workup

  • CBC
  • ESR
  • CRP
  • CK: Most sensitive muscle enzyme
  • Urinalysis
  • Consider:
    • LDH
    • AST/ALT
    • Aldolase
    • RF
    • ANA
    • Anti-Jo-1
    • Myositis antibody panel

Diagnosis

  • Typically requires muscle biopsy

Management

  • Prednisone 1mg/kg/day for 4-8 weeks until CK returns to reference range
  • Other treatments that rheum may prescribe:
    • Methotrexate as second line for poor response to corticosteroids
    • Other agents with less evidence: IVIG, TNF Inhibitors
  • Assess for interstitial lung disease
    • CXR, consider CT chest
    • Pulmonary function tests (PFTs)
  • Screen for associated malignancy, especially:[1]
    • Ovarian
    • Lung
    • Pancreatic
    • Stomach
    • Colorectal
    • Lymphoma
    • Bladder

Disposition

  • Rheumatology or neurology consultation either in ED or as outpatient depending on severity of symptoms

See Also

References

  1. Hill CL et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001 Jan 13;357(9250):96-100.